Financial reports
10-K
2023 FY
Annual report
13 Feb 24
10-Q
2023 Q3
Quarterly report
26 Oct 23
10-Q
2023 Q2
Quarterly report
28 Jul 23
10-Q
2023 Q1
Quarterly report
28 Apr 23
10-K
2022 FY
Annual report
10 Feb 23
10-Q
2022 Q3
Quarterly report
28 Oct 22
10-Q
2022 Q2
Quarterly report
29 Jul 22
10-Q
2022 Q1
Quarterly report
29 Apr 22
10-K
2021 FY
Annual report
11 Feb 22
10-Q
2021 Q3
Quarterly report
21 Oct 21
Current reports
8-K
Onemain Holdings, Inc. Reports Fourth Quarter 2023 Results
7 Feb 24
8-K
Entry into a Material Definitive Agreement
13 Dec 23
8-K
Entry into a Material Definitive Agreement
14 Nov 23
8-K
Entry into a Material Definitive Agreement
22 Jun 23
8-K
Entry into a Material Definitive Agreement
20 Jun 23
8-K
Other Events
28 Apr 22
8-K
Other Events
10 Nov 21
8-K
Entry into a Material Definitive Agreement
11 Aug 21
8-K
Entry into a Material Definitive Agreement
6 Aug 21
8-K
Entry into a Material Definitive Agreement
22 Jun 21
Registration and prospectus
424B5
Prospectus supplement for primary offering
12 Dec 23
FWP
Free writing prospectus
11 Dec 23
424B3
Prospectus supplement
11 Dec 23
424B5
Prospectus supplement for primary offering
13 Nov 23
424B5
Prospectus supplement for primary offering
13 Nov 23
FWP
Free writing prospectus
9 Nov 23
424B3
Prospectus supplement
9 Nov 23
S-3ASR
Automatic shelf registration
13 Oct 23
424B5
Prospectus supplement for primary offering
21 Jun 23
FWP
Free writing prospectus
20 Jun 23
Proxies
No filings
Other
CT ORDER
Confidential treatment order
9 Jun 15
EFFECT
Notice of effectiveness
8 Nov 13
UPLOAD
Letter from SEC
9 Feb 12
CORRESP
Correspondence with SEC
20 Dec 11
UPLOAD
Letter from SEC
9 Dec 11
CORRESP
Correspondence with SEC
26 Oct 11
CORRESP
Correspondence with SEC
6 Oct 11
UPLOAD
Letter from SEC
29 Sep 11
CT ORDER
Confidential treatment order
12 Aug 11
CERTNYS
Certification of approval for NYSE listing
28 Dec 09